MedPath

to study the effectiveness of mannitol with routine local anesthesia in nerve blocks

Phase 4
Registration Number
CTRI/2022/10/046921
Lead Sponsor
radhika singh
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Individuals between the ages of 16 and 35 years who have no allergy to mannitol and lidocaine will be included in the study.

2.Individuals who require bilateral local anesthetic nerve blocks within same arch.

Exclusion Criteria

1.Subjects allergic to mannitol or lidocaine or with any underlying systemic disease or history of significant medication that would alter pain perception.

2.Pregnant and lactating mothers will be excluded from the study.

3.Patients with restricted mouth opening/ difficulty in mouth opening will be excluded from the study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath